Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Abbott buys i-Stat in deal worth $392mm

Executive Summary

Abbott Laboratories is acquiring all issued and outstanding shares of i-Stat (point-of-care blood analysis) that it does not already own (91.8%) for $15.35 per share, a 23% premium.
Deal Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Hematology, Coagulation
    • Therapeutic Drug Monitoring
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register